ANVS
Annovis Bio (ANVS)
NYSE
$1.82-$0.04 (-2.10%)
Price as of Jun 03, 2026 7:47 PM EDT
  • $81.7M
    Market Cap
  • -28.74%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-25.2M
+26.11%
-20.0M
-48.45%
-38.8M
+134.87%
-16.5M
+94.78%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
29.7M
+11.24%
26.7M
-40.72%
45.0M
+76.53%
25.5M
+75.49%
Operating Profit
-29.7M
+11.24%
-26.7M
-40.72%
-45.0M
+76.53%
-25.5M
+75.49%
Interest Income
699,061
+110.66%
331,849
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
699,061
+110.66%
331,849
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
841,061
-60.04%
2.1M
+118.84%
-11.2M
-6,213.06%
182,712
+264.77%
Income before Taxes
-29.7M
+11.24%
-26.7M
-52.50%
-56.2M
+121.90%
-25.3M
+74.83%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-28.9M
+17.34%
-24.6M
-56.25%
-56.2M
+121.90%
-25.3M
+74.83%
Net Income from Continuing Operations Applicable to Common
-28.9M
+17.34%
-24.6M
-56.25%
-56.2M
+121.90%
-25.3M
+74.83%
Basic EPS and Net Income
-1.40
-30.69%
-2.02
-67.58%
-6.23
+100.97%
-3.10
+63.16%
Diluted EPS and Net Income
-1.40
-39.39%
-2.31
-62.92%
-6.23
+100.97%
-3.10
+63.16%
Basic Weighted Average Shares
20.6M
+68.70%
12.2M
+35.01%
9.0M
+10.55%
8.2M
+7.03%
Diluted Weighted Average Shares
20.6M
+67.97%
12.2M
+35.60%
9.0M
+10.55%
8.2M
+7.03%
Balance Sheet
Cash and Cash Equivalents
19.5M
+85.11%
10.6M
+83.36%
5.8M
-79.72%
28.4M
-37.89%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
19.5M
+85.11%
10.6M
+83.36%
5.8M
-79.72%
28.4M
-37.89%
Total Current Assets
19.5M
+85.11%
10.6M
+3.37%
10.2M
-71.66%
36.0M
-21.69%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
21.1M
+51.39%
13.9M
+36.42%
10.2M
-71.66%
36.0M
-21.69%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
3.6M
-6.33%
3.9M
-9.30%
4.3M
-44.42%
7.7M
+411.02%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
100,000
N/A
0
-100.00%
13.7M
N/A
N/A
N/A
Total Liabilities
4.2M
-8.39%
4.6M
-74.29%
18.0M
+133.28%
7.7M
+411.02%
Retained Earnings
-163.7M
+21.40%
-134.8M
+22.30%
-110.3M
+103.98%
-54.1M
+88.17%
Total Stockholders Equity
16.9M
+81.05%
9.3M
+220.09%
-7.8M
-127.37%
28.3M
-36.34%
Total Shares Outstanding
27.2M
+92.34%
14.1M
+34.43%
10.5M
+28.86%
8.2M
+0.78%
Cash Flow
Cash from Operating Activities
-25.6M
+17.01%
-21.9M
-45.22%
-40.0M
+130.85%
-17.3M
+89.58%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
34.6M
+29.63%
26.7M
+53.89%
17.3M
+375,888.10%
4,613
-99.99%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-164.85%
-19.11%
-203.78%
-16.19%
-243.15%
+293.70%
-61.76%
+15.36%
Return on Equity
-220.61%
-93.02%
-3,159.09%
+478.17%
-546.40%
+685.43%
-69.57%
+24.94%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.37
+97.61%
2.72
+13.97%
2.39
-49.02%
4.68
-84.68%
Cash Ratio
5.37
+97.61%
2.72
+102.18%
1.34
-63.52%
3.69
-87.84%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow